NCT05243875Active, not recruiting
Lupus Education Alliance Program
Source: ClinicalTrials.gov · Last updated 26 Oct 2026
Brief summary (registry, in English)
Randomized controlled trial of a COVID-19 behavioral and educational intervention for people with systemic lupus erythematosus (SLE).
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 274 (actual)
- First submitted
- 15 Nov 2021
- Start date
- 1 Nov 2023
- Primary completion date
- Jan 2027
- Lead sponsor
- Tulane University
- Diseases
- Lupus (SLE)
- NCT number
- NCT05243875
What you commit to
- Study type: Interventional
- Participants enrolled: 274
- From 1 Nov 2023 to the primary completion date, Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- 18 years or older, ability to understand and speak English, diagnosis of SLE
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tulane University Coordinator of this site? Confirm its status | New Orleans | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.